Cell bank and seed lot management.

A biological starting system is more than a freezer item. Its identity is a lineage: source, construct or strain, derivation, passages, characterisation, bank manufacture, storage, vial history, authorised use and every production culture that follows.

When those facts are divided between inventory, laboratory notebooks, freezer maps, certificates and batch records, an organisation can know how many vials remain without knowing which ones may be used, or which released products a newly discovered concern affects.

Why teams choose Seal for cell banks and seed lots

The gap usually sits at the boundary between cryogenic inventory and biological genealogy: a repository system manages boxes, a LIMS manages tests and an MES manages culture execution, and a bank concern is traced across all three by hand. Seal holds the bank, its characterisation, each vial and each withdrawal as one lineage, and connects them to the question that matters: can this vial initiate this use now, and what is affected if its lineage changes? An impact assessment then starts from the genealogy, with each included and excluded branch stated. The same model supports biologics, vaccines, viral vectors, cell therapies, microbial fermentation, challenge organisms and reference strains without flattening their scientific differences.

1Source and derivation form one executable lineage.

The source keeps its provenance: species, tissue or isolate, donor or host where applicable, collection, origin, biosafety, genetic background and restrictions. For recombinant systems, construct identity, sequence version, vector, clone selection and editing history join the lineage, so the bank is never reduced to a material code.

Cell banks, virus seeds, microbial seed lots, production strains and reference cultures share concepts such as parentage, generation, characterisation, storage and withdrawal. Their specific controls stay explicit, because passage terminology, attenuation, adventitious-agent expectations and strain authentication vary by organism and purpose.

The approved derivation defines source material, culture conditions, critical raw materials, manipulations, clone or plaque selection, passages, harvest, fill and freeze. Execution records every transformation, so a bank lot links to its parent container and culture history rather than to a protocol title. Passage or generation is computed from recorded events using the organisation’s approved convention. Maximum passage, generation or population-doubling limits gate both bank creation and production use.¹ A manual override requires a visible rationale and authorisation.

2Characterisation and release decide what a bank may be used for.

Required characterisation resolves by bank type, organism, product, stage and market: identity, sterility, mycoplasma, adventitious agents, genetic stability and potency among others. For cell lines of human or animal origin, viral testing of master and working banks is part of the wider viral safety strategy.² Each result stays linked to its sample, method and bank, so the dependencies can be queried at any time rather than assembled for an inspection.

Release can carry conditions: acceptable interim evidence, future commitments, restricted uses, maximum passages, named products or facilities and requalification dates. Quarantined, conditionally authorised, released, restricted, under investigation, exhausted and retired are distinct states. Availability derives from quality state and passage limits as well as vial count.

3Every vial has an identity, a position and a storage history.

Each vial belongs to a bank lot and fill event, and sits in a physical hierarchy of box, rack, freezer or tank, site and storage phase. Moves use scan-confirmed source and destination. Bulk moves, emergency relocations and split storage preserve each vial’s position history rather than replacing the previous map.

Freezer and cryogenic-vessel temperature, liquid-nitrogen level, alarms, maintenance and access connect to the vial population present during each interval. An excursion therefore resolves to exact bank lots and vials, including those moved during the event.

Filled, sampled, retained, shipped, broken, withdrawn, destroyed and remaining populations must reconcile to the fill event. Seal distinguishes uncertainty about the physical count from uncertainty about quality status; neither can hide behind a single available quantity.

4Withdrawal and thaw start the downstream lineage.

Reservation, authorisation, pick, identity verification, removal time, transport condition, receipt, thaw start and intended use form one chain-of-custody transaction. Unused vials do not casually return to stock: the approved policy evaluates temperature, time, seal and custody history before any return or alternative disposition.

The thaw links the vial to recovery, culture vessel, medium lots, operator, equipment, viability, passage events, seed train and production batch. That link supports forward trace from a bank concern to product and backward trace from a process signal to the exact source vial.

5Contamination and identity events expand through genealogy.

A failed sterility, mycoplasma, identity, adventitious-agent or genetic-stability result first controls the tested sample and the related bank population. Seal then traverses the genealogy to identify descendants, sibling banks, cultures, retained material, studies and distributed lots.

Swipe to see the full diagram →

The scope is versioned as evidence changes. Investigators can see why each lineage was included or excluded at every decision, and a new signal can change bank authorisation without rewriting historical dispositions.

6Reserve, requalification and transfer follow the bank lifecycle.

Minimum reserve, programme demand, the manufacturing schedule, testing and stability consumption, disaster-recovery allocation and lead time indicate when a new bank is needed. The planner sees the projected exhaustion date alongside the characterisation and comparability work required before a replacement may support production.

Periodic or event-driven monitoring can assess viability, identity, stability, potency and container integrity. Pulls come from governed positions and stay linked to their methods and results.

Transfers to another site, a contract manufacturer, a testing laboratory or a repository carry chain of custody, shipping configuration, agreements, biosafety, source restrictions and receipt verification. The recipient’s identifiers map to the source identity rather than starting an untraceable parallel lineage.

7Changes begin at the affected generation.

A new working bank or a changed medium, raw-material source, passage limit, storage system, characterisation method or site identifies its first affected bank and all intended descendants. Comparability and regulatory commitments attach to that branch. Pre-change and post-change production are related, but never treated as the same evidence population by default.

8Prove one difficult lineage end to end.

Follow one source through clone selection, master bank manufacture, characterisation, conditional release, working bank derivation, storage, withdrawal, thaw, seed train, production batch, product release and a later identity concern.

Include a mis-scanned location, a broken vial, a partial characterisation result, a passage-limit edge, an emergency freezer move, an unsuccessful thaw and a result that expands scope to sibling vials but excludes an unrelated branch. The first release is ready when it can answer both which vial may be used and which products descend from it.